posted on 2021-10-23, 12:03authored byAjay K Gopal, Rakesh Popat, Ryan J Mattison, Tobias Menne, Adrian Bloor, Terry Gaymes, Asim Khwaja, Mark Juckett, Ying Chen, Matthew J Cotter, Ghulam J Mufti
Supplementary
material. Medical
history of the patient in Cohort 1 who experienced possible drug-related
Grade 5 neutropenic sepsis.
Funding
This study was sponsored by Biomarin/Medivation, which was acquired by Pfizer Inc. in September 2016 (grant number not applicable).